JN Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 82: 1776-1785, 1999;
0022-3077/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madamba, S. G.
Right arrow Articles by Siggins, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madamba, S. G.
Right arrow Articles by Siggins, G. R.

The Journal of Neurophysiology Vol. 82 No. 4 October 1999, pp. 1776-1785
Copyright ©1999 by the American Physiological Society

Nociceptin Augments K+ Currents in Hippocampal CA1 Neurons by Both ORL-1 and Opiate Receptor Mechanisms

Samuel G. Madamba, Paul Schweitzer, and George Robert Siggins

The Scripps Research Institute, Department of Neuropharmacology, La Jolla, California 92037

Madamba, Samuel G., Paul Schweitzer, and George Robert Siggins. Nociceptin Augments K+ Currents in Hippocampal CA1 Neurons by Both ORL-1 and Opiate Receptor Mechanisms. J. Neurophysiol. 82: 1776-1785, 1999. We previously reported (see also the accompanying paper) that dynorphin A significantly enhanced the voltage-dependent K+ M-current (IM) in CA3 and CA1 hippocampal pyramidal neurons (HPNs). Because the opioid-receptor-like-1 (ORL-1) receptor shares a high sequence homology with opioid receptors and is expressed in rat hippocampus, we examined the effects of orphanin FQ or nociceptin, the endogenous ligand for the ORL-1 receptor, using the rat hippocampal slice preparation and intracellular voltage-clamp recording. Current-voltage (I-V) relationships from CA1 HPNs revealed that nociceptin superfusion induced an outward current reversing near the equilibrium potential for K+ ions. Ba2+ (2 mM) blocked this effect. The nociceptin-induced current was largest at depolarized membrane potentials, where IM is largely activated. Nociceptin concentrations of 0.5-1 µM (but not 0.1 µM) significantly increased IM relaxation amplitudes with recovery on washout. Interestingly, both the general opiate antagonist naloxone and the kappa  receptor antagonist nor-binaltorphimine (nBNI) inhibited the nociceptin-induced IM increases and outward currents in the depolarized range but not the inward current induced at hyperpolarized potentials. The putative ORL-1 receptor antagonist, [Phe1Psi (CH2-NH)Gly2]NC(1-13)NH2 (hereafter ORLAn), blocked most of the nociceptin current near rest but not the IM increase. However, ORLAn alone had direct effects similar to those of nociceptin, indicating that ORLAn might be a partial agonist. Our results suggest that nociceptin postsynaptically modulates the excitability of HPNs through ORL-1 and kappa -like opiate receptors linked to different K+ channels.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Roberto and G. R. Siggins
Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala
PNAS, June 20, 2006; 103(25): 9715 - 9720.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
S. Meis
Nociceptin/Orphanin FQ: Actions within the Brain
Neuroscientist, April 1, 2003; 9(2): 158 - 168.
[Abstract] [PDF]


Home page
J. Neurophysiol.Home page
M. V. Baratta, T. Lamp, and M. K. Tallent
Somatostatin Depresses Long-Term Potentiation and Ca2+ Signaling in Mouse Dentate Gyrus
J Neurophysiol, December 1, 2002; 88(6): 3078 - 3086.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Bregola, S. Zucchini, D. Rodi, A. Binaschi, C. D'Addario, D. Landuzzi, R. Reinscheid, S. Candeletti, P. Romualdi, and M. Simonato
Involvement of the Neuropeptide Nociceptin/Orphanin FQ in Kainate Seizures
J. Neurosci., November 15, 2002; 22(22): 10030 - 10038.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. H. Chin, K. Harris, D. MacTavish, and J. H. Jhamandas
Nociceptin/Orphanin FQ Modulation of Ionic Conductances in Rat Basal Forebrain Neurons
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 188 - 195.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. K. Tallent, S. G. Madamba, and G. R. Siggins
Nociceptin Reduces Epileptiform Events in CA3 Hippocampus via Presynaptic and Postsynaptic Mechanisms
J. Neurosci., September 1, 2001; 21(17): 6940 - 6948.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online